MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-03-2026
Agilent Technologies Operating Cash Flow 2011-2026 | A
Annual Operating Cash Flow Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.48 B | 921 M | 1.02 B | 1.09 B | 889 M | 793 M | 512 M | 731 M | 1.15 B | 1.23 B | 1.26 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.48 B | 512 M | 1.01 B |
Quarterly Operating Cash Flow Agilent Technologies
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 268 M | - | - | 431 M | - | - | 485 M | - | 255 M | - | - | - | 238 M | - | 710 M | - | -59 M | 544 M | 254 M | - | 213 M | 707 M | 465 M | - | 215 M | 715 M | 518 M | - | 116 M | 601 M | 373 M | - | 111 M | 559 M | 365 M | - | -20 M | 271 M | 163 M | - | 194 M | 547 M | 519 M | - | 245 M | 775 M | 560 M | - | 150 M | 743 M | 503 M | - | 120 M | 750 M | 498 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 775 M | -59 M | 392 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Celcuity
CELC
|
-153 M | $ 140.25 | -0.06 % | $ 6.56 B |  USA |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 4.13 | 72.81 % | $ 5.49 M | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
64.3 M | $ 20.63 | 3.0 % | $ 598 M | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 17.33 | 5.61 % | $ 524 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-185 M | $ 120.53 | 4.84 % | $ 15.1 B | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 21.8 | 3.07 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 115.87 | 0.68 % | $ 9.56 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.8 | - | $ 7.96 M | USA |
 |
Illumina
ILMN
|
837 M | $ 143.06 | 0.8 % | $ 22.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Lantheus Holdings
LNTH
|
390 M | $ 95.21 | -0.92 % | $ 6.43 B | USA |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 157.58 | 0.95 % | $ 7.81 B | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 422.03 | 0.04 % | $ 12.2 B | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 082.7 | -0.04 % | $ 22.3 B |  Schweiz |
 |
NeoGenomics
NEO
|
5.23 M | $ 9.01 | 1.24 % | $ 1.15 B | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 19.1 | -0.86 % | $ 428 M | USA |
 |
Natera
NTRA
|
-432 M | $ 208.58 | 1.79 % | $ 20.5 B | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 3.78 | -0.79 % | $ 350 M | USA |
 |
Personalis
PSNL
|
-74.9 M | $ 8.49 | 6.79 % | $ 758 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 5.78 | 1.23 % | $ 241 M | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.42 | 3.16 % | $ 5.56 M | USA |
 |
Thermo Fisher Scientific
TMO
|
7.82 B | $ 449.74 | -0.42 % | $ 170 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 254.31 | -1.17 % | $ 21.2 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 53.76 | 0.19 % | $ 3.22 B | USA |
 |
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.62 | 1.89 % | $ 223 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 8.53 | -3.45 % | $ 1.85 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 192.89 | -0.43 % | $ 21.4 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |